# Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

> **NCT02120547** · PHASE1 · COMPLETED · sponsor: **Tobira Therapeutics, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Liver Insufficiency

## Interventions

- **DRUG:** Cenicriviroc in mild liver impaired
- **DRUG:** Cenicriviroc in moderate liver impaired

## Key facts

- **NCT ID:** NCT02120547
- **Lead sponsor:** Tobira Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120547, "Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02120547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*